140 results on '"Lombardo, Mary-Jane"'
Search Results
2. Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection.
3. Impact of a Purified Microbiome Therapeutic on Abundance of Antimicrobial Resistance Genes in Patients With Recurrent Clostridioides difficile Infection
4. Reply to Lagier et al
5. Manufacturing Processes of a Purified Microbiome Therapeutic Reduce Risk of Transmission of Potential Bacterial Pathogens in Donor Stool
6. The PapC Usher Forms an Oligomeric Channel: Implications for Pilus Biogenesis across the Outer Membrane
7. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents Recurrent Clostridium difficile Infection
8. Stressful Lifestyle-Associated Mutation in Microorganisms
9. Manufacturing Process of Investigational Microbiome Therapeutic, SER-109, Reduces Risk of Bacterial Pathogen Transmission
10. A Phase 1b Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of an Investigational Microbiome Therapeutic, SER-155, in Adults Undergoing Hematopoietic Stem Cell Transplantation
11. Manufacturing Process of SER-109, a Purified Investigational Microbiome Therapeutic, Reduces Risk of Coronavirus Transmission From Donor Stool
12. Assessment of a rationally-designed experimental microbial consortium to reduce systemic inflammation in a murine model of chemotherapy-induced mucositis.
13. A phase 1b study to evaluate safety, tolerability, pharmacokinetics, and efficacy of SER-155 in adults undergoing hematopoietic stem cell transplantation to reduce the risk of infection and graft versus host disease (NCT04995653).
14. Candidate phylum TM6 genome recovered from a hospital sink biofilm provides genomic insights into this uncultivated phylum
15. Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks
16. An in vivo Expression Technology Screen for Vibrio cholerae Genes Expressed in Human Volunteers
17. SER-109, an Oral Microbiome Therapy for Recurrent Clostridioides difficile Infection
18. 1035. Manufacturing Processes of SER-109, a Purified Investigational Microbiome Therapeutic, Reduce Risk of Transmission of Emerging and Undetected Infections in Donor Stool
19. 130. Design and Preclinical Characterization of SER-155, an Investigational Cultivated Microbiome Therapeutic to Restore Colonization Resistance and Prevent Infection in Patients Undergoing Hematopoietic Stem Cell Transplantation
20. LB15. SER-109, an Investigational Microbiome Therapeutic, Reduces Abundance of Antimicrobial Resistance Genes in Patients with Recurrent Clostridioides difficile Infection (rCDI) after Standard-of-Care Antibiotics
21. Efficacy and Safety of Investigational Microbiome Drug SER-109 for Treatment of Recurrent Clostridioides difficile Infection
22. Prospective longitudinal evaluation of microbiome diversity in patients with hematological malignancy undergoing allogeneic hematopoietic stem cell transplantation (HSCT).
23. Impact of Investigational Microbiome Therapeutic SER-155 on Pathogen Domination: Initial Results from a Phase 1b Study in Adults Undergoing Allogeneic Hematopoietic Cell Transplantation (HCT)
24. Prospective longitudinal evaluation of microbiome diversity in patients with hematological malignancy undergoing allogeneic hematopoietic stem cell transplantation (HSCT).
25. Fr572 24-WEEK EFFICACY AND SAFETY DATA FROM ECOSPOR-III, A PHASE 3 DOUBLE-BLIND, PLACEBO-CONTROLLED RANDOMIZED TRIAL OF SER-109, AN INVESTIGATIONAL MICROBIOME THERAPEUTIC FOR TREATMENT OF RECURRENT CLOSTRIDIOIDES DIFFICILE INFECTION
26. General stress response regulator RpoS in adaptive mutation and amplification in Escherichia coli
27. Identity and Function of a Large Gene Network Underlying Mutagenic Repair of DNA Breaks
28. Hypermutation in stationary-phaseE. coli: tales from thelac operon
29. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial
30. radC102 of Escherichia coli is an allele of recG
31. The σE stress response is required for stress-induced mutation and amplification in Escherichia coli
32. Genome‐wide hypermutation in a subpopulation of stationary‐phase cells underlies recombination‐dependent adaptive mutation
33. Mismatch repair in Escherichia coli cells lacking single-strand exonucleases ExoI, ExoVII and RecJ
34. Regulation of Salmonella typhimurium pepT gene by cyclic AMP receptor protein (CRP) and FNR acting at a hybrid CRP-FNR site
35. xni-deficient Escherichia coli are proficient for recombination and multiple pathways of repair
36. SER-109, an Investigational Microbiome Drug to Reduce Recurrence After Clostridioides difficile Infection: Lessons Learned From a Phase 2 Trial.
37. Mechanisms of Genome-Wide Hypermutation in Stationary Phasea
38. Recombination-dependent mutation in Escherichia coli occurs in stationary phase
39. Stationary-phase mutation in the bacterial chromosome: Recombination protein and DNA polymerase IV dependence
40. Reply to Lagier et al
41. A Novel Microbiome Therapeutic Increases Gut Microbial Diversity and Prevents RecurrentClostridium difficileInfection
42. A phase 1b study to evaluate the efficacy, safety, and pharmacokinetics of an investigational microbiome therapeutic, SER-155, in adults undergoing hematopoietic stem cell transplantation.
43. Atypical Role for PhoU in Mutagenic Break Repair under Stress in Escherichia coli
44. Vancomycin-Resistant Enterococcal iters Diminish Among Patients With Recurrent Clostridium difficile Infection After Administration of SER-109, A Novel Microbiome Agent
45. Critical Microbiological View of SER-109.
46. Genome of the pathogen Porphyromonas gingivalis recovered from a biofilm in a hospital sink using a high-throughput single-cell genomics platform
47. Physical mapping of the Escherichia coli pepT and potABCD genes
48. Genomic insights to SAR86, an abundant and uncultivated marine bacterial lineage
49. Efficient de novo assembly of single-cell bacterial genomes from short-read data sets
50. Going Deeper: Metagenome of a Hadopelagic Microbial Community
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.